Pharmaceutical Sector

Cheer in Covid times

Here's the backstory of Biocon's Alzumab which has been approved by the CDSCO for the treatment of Covid-19 in India

Hindustan Antibiotics seeks redemption amid rising anti-China sentiments

The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme

Chinese firm gets approval to begin human testing for coronavirus vaccine

The potential vaccine has received a certificate from the National Medical Products Administration to launch clinical trials

Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets

The tablet is the generic of Janssen Pharmaceuticals Inc's reference listed drug product Xarelto

The discontents of decoupling

Economic delinking with China makes no sense for India; investment, growth and public welfare will suffer

Needed: A fresh look at the services sector

A post Covid-19 foreign trade policy must be cognisant of the evolving opportunities and challenges in services trade and must prepare domestic policies and capacity accordingly

Roche Pharma India expands partnership with Cipla for oncology medicines

The two companies had previously entered into a similar agreement in February 2018 for promotion and distribution of tocilizumab (Actemra) and other products

UP to amend textile, tourism policies to reboot industry, create jobs

The state signs MOUs with four leading industrial bodies to create employment for 1.1 mn returning migrants

Pharma export growth in FY20 down to single digit due to Covid: Pharmexcil

Export growth started declining in February and turned negative in March, at -23.24 per cent

After strong FY20, Alembic Pharma's FY21 outlook, too, remains firm

Domestic growth rebounds to double digits; will keep overall momentum on even keel

Vaccinating policy

IP regimes should not outweigh public health interests

Patents vs the pandemic

We should question the wisdom and morality of a system that silently condemns millions of human beings to suffering

The self-reliance myth

It is not just that we all, in our personal lives, have rediscovered to our dismay that dependence on too many other people leaves us exposed during crises

No APIs, drugs shortage in India due to coronavirus: Sadananda Gowda

Announces one API, one medical device park in Gujarat

Pharma shares in focus; Pfizer hits record high, Sun Pharma rallies 6%

Metropolis Healthcare, Bliss GVS Pharma, RPG Life Sciences, Dr. Lal PathLabs, Biocon, Albert David and FDC from the index were up more than 3 per cent.

Budget 2020: Jan Aushadhi growth could hurt branded pharma market

In the 2020-21 Union Budget, finance minister Nirmala Sitharaman proposed to expand the scheme to all districts, and offer 2,000 medicines and 300 surgicals by 2024

Novartis buys Aspen's Japanese generic unit for up to 400 million euros

Aspen Pharmacare has abandoned its dividend this year and is selling assets to pay down debt after levels moved close to breaching debt covenants

GSK gains 38% over 3 months, gets boost from tighter low-end portfolio

Revenue growth, margins have been trending up over the past couple of quarters

China opens public hospitals for Dr Reddy's Laboratories generic drugs

First Indian firm to get contract for supplying generic schizophrenia drug to public hospitals there

10 years of pharmaceutical sector: Controls, regulations stymie growth

It has also been a decade of major mergers and acquisitions, the most noteworthy one perhaps being the Sun Pharma-Ranbaxy deal